|本期目录/Table of Contents|

[1]仇佳丽,蒋文涛,张骊,等.加速康复外科促进胃肠道功能恢复在肝移植术后早期的临床应用[J].天津医科大学学报,2021,27(04):379-383.
　QIU Jia-li,JIANG Wen-tao,ZHANG Li,et al.Clinical application of enhanced recovery after surgery by promoting gastrointestinal function recovery in the early stage after liver transplantation[J].Journal of Tianjin Medical University,2021,27(04):379-383.
点击复制

加速康复外科促进胃肠道功能恢复在肝移植术后早期的临床应用(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27卷
期数:
2021年04期
页码:
379-383
栏目:
临床医学
出版日期:
2021-07-20

文章信息/Info

Title:
Clinical application of enhanced recovery after surgery by promoting gastrointestinal function recovery in the early stage after liver transplantation
文章编号:
1006－8147（2021）04-0379-05
作者:
仇佳丽1; 蒋文涛2; 张骊2; 田大治2; 李俊杰2; 崔玉军2; 陈池义2; 李江2
（1. 天津医科大学一中心临床学院，天津 300192；2.天津市第一中心医院肝移植科，天津市器官移植重点实验室，中国医学科学院移植医学重点实验室，天津300192）
Author(s):
QIU Jia-li1; JIANG Wen-tao2; ZHANG Li2; TIAN Da-zhi2; LI Jun-jie2; CUI Yu-jun2; CHEN Chi-yi2; LI Jiang2
（1.Tianjin Medical University First Center Clinical College，Tianjin 300192，China；2.Department of Liver Transplantation，Tianjin First Central Hospital，Tianjin Key Laboratory of Organ Transplantation，Key Laboratory of Transplantation Medicine，Chinese Academy of Medical Sciences，Tianjin 300192，China）
关键词:
肝移植; 加速康复外科; 胃肠道功能; 肝功能; 营养状态; 术后恢复
Keywords:
liver transplantation;  enhanced recovery after surgery;  gastrointestinal function;  liver function;  nutritional status;  postoperative recovery
分类号:
R619
DOI:
-
文献标志码:
A
摘要:
目的：观察肝移植术后早期应用促进胃肠道功能恢复的加速康复外科（ERAS）理念的临床效果。方法：以2017年4月—2018年6月在天津市第一中心医院行原位肝移植术的成人患者为研究对象，根据是否采用促进胃肠道功能恢复的ERAS理念将患者分为ERAS组（121例）和非ERAS组（102例）。ERAS组应用ERAS理念，促进术后早期胃肠道功能恢复；非ERAS组给予常规围手术期处理。比较分析两组患者的排气时间、术后2周肝功能及营养指标、术后感染发生率、住院时间、住院费用等。结果：ERAS组术后2周总胆红素（TBil）为18.20（11.95，34.40）μmol/L，较非ERAS组[24.77（15.30，37.64）μmol/L]低（t=2.411，P=0.016），?酌-谷氨酰转肽酶（GGT）为133.30（88.45，196.30） U/L，较非ERAS组[ 160.90（101.03，271.00）U/L]低（z=-2.062，P=0.039）；ERAS组术后2周白蛋白（ALB）为（40.78±4.00）g/L，较非ERAS组[（38.72±4.69）g/L]高（t=3.529，P=0.001）；ERAS组排气时间为1.00（1.00,2.00） d，较非ERAS组[3.00（2.00，3.00） d]早（z=8.328，P=0.000）；ERAS组患者在ICU住院时间为3.00（2.00，3.00） d，较非ERAS组[3.00（3.00，4.00） d]少（z=-5.103，P=0.000）；ERAS组住院时间[27.00（22.00，38.00） d]较非ERAS组[35.00（26.00，74.50） d]短（z=-4.127，P=0.000）；ERAS组住院费用[27.90（24.28，32.30） 万元]较非ERAS组[32.03（27.39，38.73） 万元]少（z=-4.634，P=0.000）；在术后并发症中，感染相关的并发症存在明显差异，两组感染率分别为28.1%和40.2%（χ2=3.628，P=0.047）。结论：ERAS术后早期促进胃肠功能恢复的理念在肝移植术后临床应用有效，有助于术后早期肝功能恢复和营养状态改善，减少住院时间及住院费用。
Abstract:
Objective: To observe the clinical effect of promoting gastrointestinal function recovery in enhanced recovery after surgery （ERSA） in the early stage after liver transplantation. Methods: Adult patients who underwent orthotopic liver transplantation in Tianjin First Central Hospital from April 2017 to June 2018 were selected as the research object，and the patients were divided into ERAS group （n=121）and non-ERAS group（n=102）according to whether the concept of promoting gastrointestinal function recovery in enhanced recovery after surgery was adopted.The ERAS group applied the concept of ERAS to optimize the early postoperative recovery of gastrointestinal function. While the non-ERAS group was given routine perioperative treatment. The exhaust time，liver function and nutritional indicatorsin 2 weeks after operation，postoperative infection incidence，hospitalization time，hospitalization expenses，etc. of the two groups of patients were compared and analyzed. Results：The total bilirubin（TBil） of [18.20（11.95，34.40）μmol/L] in the ERAS group was lower than that[24.77（15.30，37.64）μmol/L] of the non-ERAS group at 2 weeks postoperatively（t=2.411，P=0.016）. And the ?酌-glutamyltranspeptidase （GGT） [133.30（88.45，196.30） U/L] in the ERAS group was lower than that [160.90（101.03，271.00） U/L] of the non-ERAS group at 2 weeks postoperatively（z=-2.062，P=0.039）. The albumin（ALB） at 2 weeks after the operation in the ERAS group were （40.78±4.00） g/L，which were higher than those in the non-ERAS group at 2 weeks after the operation，which were （38.72±4.69） g/L（t=3.529，P=0.001）. The exhaust time [1.00（1.00，2.00） d] of ERAS group was earlier than non-ERAS group [3.00 （2.00，3.00） d] （z=8.328，P=0.000）. The length of the patients′ stay in the ICU[3.00（2.00，3.00） d] was decreased in the ERAS group compared with [3.00 （3.00，4.00） d] in the non-ERAS group（z=-5.103，P=0.000）. The hospital stay in the ERAS group [27.00（22.00，38.00）d] was shorter than that of the non-ERAS group[35.00（26.00，74.50）d]（z=-4.127，P=0.000）. The cost of hospitalization in the ERAS group was [27.90（24.28，32.30） ten thousand yuan] less than that of the non-ERAS group，which was[32.03（27.39，38.73） ten thousand yuan] （z=-4.634，P=0.000）. In the postoperative complications，the infection related complications were significantly different，the infection rates in the two groups were 28.1% and 40.2%，respectively（χ2=3.628，P=0.047）. Conclusion: The concept of promoting early recovery of gastrointestinal function inenhanced recovery after surgery is effective in clinical application after liver transplantation. It is helpful for early recovery of liver function and nutritional status after operation，and reduces hospitalization time and cost.

参考文献/References:

[1] Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation[J]. Br J Anaesth，1997，78（5）：606
[2] Chandrakantan A，Gan T J. Demonstrating value： acase study of enhanced recovery[J]. Anesthesiol Clin，2015，33（4）：629
[3] Carter J. Fast-track surgery in gynaecology and gynaecologic oncology：a review of a rolling clinical audit[J]. ISRN Surg，2012，2012：368014
[4] Brustia R，Monsel A，Conti F，et al. Enhanced recovery in liver transplantation：a feasibility study[J]. World J Surg，2019，43（1）：230
[5] Shergill R，Syed W，Rizvi S A，et al. Nutritional support in chronic liver disease and cirrhotics[J]. World J Hepatol，2018，10（10）：685
[6] Johnson T M，Overgard E B，Cohen A E，et al. Nutrition assessment and management in advanced liver disease[J]. Nutr Clin Pract，2013，28（1）：15
[7] Anastacio L R，Ferreira L G，Ribeiro H S，et al. Weight loss during cirrhosis is related to the etiology of liver disease[J]. Arq Gastroenterol，2012，49（3）：195
[8] Bajaj J S，Kakiyama G，Cox I J，et al. Alterations in gut microbial function following liver transplant[J]. Liver Transpl，2018，24（6）：752
[9] Esmat G M，Pirenne J，Van Malenstein H，et al. Risk factors for bleeding and clinical implications in patients undergoing liver transplantation[J]. Transplant Proc，2012，44（9）：2857
[10] 黎介寿. 营养支持治疗与加速康复外科[J]. 肠外与肠内营养，2015，22（2）：65
[11] Taha A M I，Sharif K，Johnson T，et al. Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease[J]. J Pediatr Gastroenterol Nutr，2012，
54（4）：547
[12] 中国医师协会器官移植分会移植免疫学组，中华医学会外科学分会手术学组，广东省医师协会器官移植医师分会. 加速康复外科优化重型肝炎肝移植围手术期管理临床实践的专家共识[J]. 器官移植，2017，8（4）：251
[13] Stoot J H，van Dam R M，Busch O R，et al. The effect of a multimodal fast-track programme on outcomes in laparoscopic liver surgery： a multicentre pilot study[J]. HPB （Oxford），2009，11（2）：140
[14] Dienstag J L，Cosimi A B. Liver transplantation-a vision realized[J]. N Engl J Med，2012，367（16）：1483
[15] Washburn W K，Meo N A，Halff G A，et al. Factors influencing liver transplant length of stay at two large-volume transplant centers[J]. Liver Transpl，2009，15（11）：1570
[16] Chandok N. Polycystic liver disease： a clinical review[J]. Ann hepatol，2012，11（6）：819
[17] Mathurin P，Deng Q G，Keshavarzian A，et al. Exacerbation of alcoholic liver injury by enteral endotoxin in rats[J]. Hepatology，2000， 32（5）：1008
[18] Enomoto N，Takei Y，Yamashima S，et al. Protective effect of pioglitazone against endotoxin-induced liver injury through prevention of Kupffer cell sensitization[J]. Alcohol Clin Exp Res，2005，29（12 Suppl）：216S
[19] Kono H，Fujii H，Amemiya H，et al. Role of Kupffer cells in lung injury in rats administered endotoxin 1[J]. J Surg Res，2005，129（2）：176
[20] Coltman A，Peterson S，Roehl K，et al. Use of 3 tools to assess nutrition risk in the intensive care unit[J]. J Parenter Enteral Nutr，2015，
39（1）：28
[21] 国家卫生计生委医管中心加速康复外科专家委员会. 中国肝移植围手术期加速康复管理专家共识（2018版）[J]. 中华普通外科杂志，2018，33（3）：268
[22] 刘剑戎，许世磊，安玉玲，等. 早期肠内营养对重症肝炎肝移植患者术后恢复的影响[J]. 中华肝脏外科手术学电子杂志，2015（5）：306
[23] 柳东夫，于胜强，万峰春，等. 加速康复外科在肾移植领域的应用[J]. 中华器官移植杂志，2019，40（12）：734
[24] Xu Q，Zhu M，Li Z，et al. Enhanced recovery after surgery protocols in patients undergoing liver transplantation： a retrospective comparative cohort study[J]. Int J Surg，2020，78：108
[25] Kim J M，Joh J，Kim H J，et al. Early enteral feeding after living donor liver transplantation prevents infectious complications[J]. Medicine （Baltimore），2015，94（44）：e1771

相似文献/References:

[1]罗宇涵,蒋文涛,李俊杰.索拉非尼治疗肝移植后肝细胞癌复发的单中心回顾性分析[J].天津医科大学学报,2021,27(01):43.
　LUO Yu-han,JIANG Wen-tao,LI Jun-jie.Single center retrospective analysis of sorafenib in the treatment of hepatocellular carcinoma recurrence after liver transplantation[J].Journal of Tianjin Medical University,2021,27(04):43.
[2]高犇,代星,李江.改良查尔森合并症指数对老年患者肝移植术后早期并发症的评估价值[J].天津医科大学学报,2023,29(02):178.
　GAO Ben,DAI Xing,LI Jiang.Evaluation of the modified Charlson comorbidity index for predicting early complications after liver transplantation in elderly patients[J].Journal of Tianjin Medical University,2023,29(04):178.
[3]曹义,彭玉娜,胡芳,等.儿童肝移植非计划性术中低体温风险预测模型的构建及验证[J].天津医科大学学报,2024,30(01):6.[doi:10.20135/j.issn.1006-8147.2024.01.0006]
　CAO Yi,PENG Yuna,HU Fang,et al.Construction and validation of a risk prediction model for pediatric liver transplantation with unplanned intraoperative hypothermia[J].Journal of Tianjin Medical University,2024,30(04):6.[doi:10.20135/j.issn.1006-8147.2024.01.0006]

备注/Memo

备注/Memo:
基金项目： 国家自然科学基金面上项目（81870444）；天津市第一中心医院春风计划（2019CF03）
作者简介：仇佳丽（1994-），女，硕士在读，研究方向：肝脏移植；通信作者：蒋文涛，E-mail: jiangwentao@nankai.edu.cn。
更新日期/Last Update: 2021-07-25